Teva Defeats Patent Infringement Claims on Endocrine Drug | ...
$40B deal: Teva offers to buy Mylan
Teva says Israel-Hamas war not hurting production, eyes growth in 2024 | Reuters
Ukraine. 29th Apr, 2021. In this photo illustration, a Teva logo of an Israel pharmaceutical company seen displayed on a smartphone and a pc screen. Credit: Pavlo Gonchar/SOPA Images/ZUMA Wire/Alamy Live News
Teva Pharmaceuticals: Israeli drugmaker to cut 14,000 jobs
Teva Pharmaceutical Industries Ltd.
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
Half a year later, Teva's 'pivot to growth' strategy appears to be bearing fruit | Fierce Pharma
Teva makes $40B offer for Mylan | The Arkansas Democrat-Gazette - Arkansas' Best News Source
Company Update (NYSE:TEVA): Teva Pharmaceutical Industries Ltd (ADR) Sells Off Last of Specialty Global Women's Health Portfolio Assets in $1.38 Billion Deal
Teva's Richard Francis launches 'pivot to growth' strategy | Fox Business Video
Teva 'Plagued By Problems,' Downgraded On Lost MS Drug Patents, DOJ Probe | Stock News & Stock Market Analysis - IBD
Teva considering $2B sale of active pharma ngredients unit | Seeking Alpha
Teva Pharmaceutical begins first wave of layoffs in Kansas - Kansas City Business Journal
Teva's two new digital inhalers complete Digihaler product line | MobiHealthNews
Watch Teva CEO on Second-Quarter, Potential DOJ Settlement - Bloomberg
Teva Pharmaceuticals, NY reach opioid lawsuit settlements worth $523M - Top Class Actions
Teva Pharmaceuticals found liable in New York opioid trial
Teva USA
Teva Pharmaceutical posts rise in Q3 2023 net income to $80m
Teva to pay $225M to settle cholesterol drug price-fixing charges | AP News
Teva to pay $225 million fine and divest cholesterol drug to settle price-fixing charges | CNN Business
Teva reaches $126M opioid settlement with hospitals - Top Class Actions
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva Pharmaceutical Industries (NYSE:TEVA) Hits New 1-Year High at $13.50 - American Banking and Market News
